PHIO:NASDAQ
Phio Pharmaceuticals Corp
$1.06
arrow_downward
-7.02%(-0.080) 1D
$1.05
arrow_downward
-0.94% (-0.0100)todayPre-market
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
$1.11
High
$1.13
Low
$1.05
Mkt. cap
12.31M
Avg. vol.
139.07K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.49
Beta
0.82
Shares outstanding
11.62M
No. of employees
6
Open
$1.11
High
$1.13
Low
$1.05
Mkt. cap
12.31M
Avg. vol.
139.07K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.49
Beta
0.82
Shares outstanding
11.62M
No. of employees
6
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to PHIO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for PHIO in the last 3 months.
Highest
Current $1.06
$14.00 (+1,220.75%)
Average
$14.00 (+1,220.75%)
Lowest
$14.00 (+1,220.75%)
News stories
From sources across the web
24/7 Wall St.
·
53 minutes ago
The Korean Stock Market Just Crashed Sunday Night. Will the Nasdaq Follow Tomorrow?
Yahoo Finance
·
42 minutes ago
VOO vs. SPY: Which ETF Is the Best Way to Buy the S&P 500?
www.moneyshow.com
·
1 hour ago
(06/08/26) SPX: The Long-Term View — and What Might Come Next
Seeking Alpha
·
2 hours ago
S&P 500: This Is More Important Than Calling A Top (Technical Analysis) (SP500)
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp
AI content may include mistakes. Learn more